|
|
Article: BRCA mutation testing warranted in women with bilateral breast cancer, regardless of family history: 25% have deleterious mutation.(News)
- Article from:
- OB GYN News
- Article date:
- January 1, 2004
- Author:
CopyrightCOPYRIGHT 2004 International Medical News Group. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
SAN ANTONIO -- Women with bilateral invasive breast cancer have a high prevalence of BRCA1 and BRCA2 mutations regardless of whether they possess a strong family history of breast or ovarian cancer, Alicia A. Parlanti reported at a breast cancer symposium sponsored by the Cancer Therapy and Research Center.
Based upon this observation in a large new study, all women with bilateral invasive breast cancer--including those in whom the first and second diagnoses are separated by decades--ought to be offered genetic risk assessment services including BRCA mutation testing, said Ms. Parlanti of Myriad Genetic Laboratories in Salt Lake City.
She reported on ...